In den Warenkorb
Bestellen Sie auch über:
+49 (0)241 95 163 153
+49 (0)241 95 163 155

Pim-1 Oncogene (PIM1) (internal) Antikörper

Antigen

Pim-1 Oncogene (PIM1)

Synonyme PIM, Pim-1, pim2, cb1068, fj47b05, wu:fj47b05, pim1-a, PIM1, pim3, MGC89574, pim-1, PAP-1
Epitope
Alternativen

internal

Klonalität Polyklonal
Wirt
Alternativen

Kaninchen

Applikation
Alternativen Immunhistochemie (IHC), Western Blot (WB)
2 Publikationen vorhanden
Produktnummer ABIN350744
Menge 100 µl
Preis 317,95 €   Zzgl. Versandkosten €20,00 und MWSt
Lieferung nach
Verfügbarkeit Lieferung in 7 bis 10 Werktagen

Produktbeschreibung

Weitere Bezeichnung PIM1 (Retinitis pigmentosa 9 protein) (internal region)
Swiss-Prot Q8TA86
Immunogen A synthetic peptide from the internal region of human PIM1 (Retinitis pigmentosa 9 protein) conjugated to an immunogenic carrier protein was used as the immunogen.
Format Lyophilized
Beschreibung FUNCTION: Is thought to be a target protein for the PIM1 kinase. May play some roles in B-cell proliferation in association with PIM1.Nucleus TISSUE SPECIFICITY: Appears to be expressed in a wide range of tissues. DISEASE: Defects in RP9 are the cause of retinitis pigmentosa type 9 (RP9). RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP9 inheritance is autosomal dominant. Also known as: Retinitis pigmentosa 9 protein, RP9, Pim-1-associated protein, PAP-1.
Spezifität Appears to be specific for PIM1.

Anwendungen

Applikationshinweise IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.
Reinheit whole serum
Lagerung Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Beschränkungen Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen Keen, Hims, McKie et al.: "Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa." in: European journal of human genetics : EJHG, Vol. 10, Issue 4, pp. 245-9, 2002 (PubMed).

Kuroda, Maita, Tabata et al.: "A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase." in: Gene, Vol. 340, Issue 1, pp. 83-98, 2004 (PubMed).

Alternativen

Alternativen zu Antigen "Pim-1 Oncogene (PIM1)", Typ "Antikörper" finden
Wirte Maus (25), Kaninchen (21)
Reaktivitäten Human (43), Maus (5), Ratte (Rattus) (5), Rind (Kuh) (1)
Applikationen Western Blot (WB) (28), Enzyme Immunoassay (EIA) (26), Immunhistochemie (Paraffinschnitte) (IHC (p)) (19), ELISA (8), Immunfluoreszenz (IF) (7), Immunhistochemie (IHC) (3), Immunzytochemie (ICC) (1), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (1), Immunpräzipitation (IP) (1)
Epitope C-Term (2)